Inicio Libros eLibros Revistas Referencias y Libros de Ponencias Autores, Editores, Críticos Índice de Productos de la A a la Z Premios
Critical Reviews™ in Oncogenesis

ISSN Imprimir: 0893-9675
ISSN En Línea: 2162-6448

Volumen 21, 2016

Volumen 20, 2015

Volumen 19, 2014

Volumen 18, 2013

Volumen 17, 2012

Volumen 16, 2011

Volumen 15, 2009

Volumen 14, 2008

Volumen 13, 2007

Volumen 12, 2006

Volumen 11, 2000

Volumen 9, 1998

Volumen 8, 1997

Volumen 7, 1996

Volumen 6, 1995

Volumen 5, 1994

Edición 1

Edición 2-3

Edición 4

Edición 5

Critical Reviews™ in Oncogenesis

Editor-in-Chief: Benjamin Bonavida

Objetivos y Alcance

The primary objective of the Critical Reviews in Oncogenesis (CRO) is the update and dissemination of scientific and clinical knowledge pertaining to the underlying molecular bases of oncogenesis by emphasizing both the journal's originality and scientific merit. CRO is dedicated to publishing timely critical reviews on topics of current interests with emphases on basic, molecular and translational applications in the field of oncogenesis. Further emphasis is focused on the roles of oncogenesis in the development of cancer and malignancies and cancer stem cells and their oncogenic potential. Reviews also consider the role of oncogenes as diagnostic biomarkers and therapeutic targets. Hence, CRO publishes special thematic issues on the above described topics and emphasizes multidisciplinary approaches.
In contrast to reviews in several other publications, CRO is highly focused on a specific and a unique thematic approach for each issue, edited by invited Editor(s), with contributions by various experts. This multidisciplinary approach for a coherent theme in Oncogenesis distinguishes CRO from many other review journal in which individual reviews that are not always interrelated, are often published. The unique Aims and Scope of CRO will lead to a wide readership and will be used as an essential reference for research scientists, clinicians, students, health professionals, and biopharmaceutical industries.

Artículos más Descargados

Pediatric Rhabdomyosarcoma
Jack F. Shern, Marielle E. Yohe, Javed Khan

Resistance to Cell Death and Its Modulation in Cancer Stem Cells
Ahmad R. Safa

The IAP Protein Family, SMAC Mimetics and Cancer Treatment
Alex Philchenkov, Koh Miura

Biology and Treatment of Rhabdoid Tumor
James I. Geller, Jacquelyn J. Roth, Jaclyn A. Biegel

Neuroblastoma
Johannes Hubertus Schulte, Angelika Eggert

Src Kinase Inhibitors: Promising Cancer Therapeutics?
Helen Creedon , Valerie G . Brunton